Regulatory troubles continue for Sun Pharma as the drug manufacturer’s ... Analysts at HSBC expect the FDA move to add to the regulatory overhang for the drugmaker, while those at Nomura ...
The recent OAI classification for Sun Pharma's Dadra unit comes on the heels ... The US Food and Drug Administration (US FDA) has released a detailed report on six observations it reported ...
The Sun Pharma's ordeal with the US drug regulator continues as its Halol Manufacturing facility in Gujarat is already under USFDA scanner facing import alert. Its Mohali unit also swaits USFDA ...
Sun Pharma Q3 results today: What to expect from India’s top ... The company’s Halol plant, receiving an import alert from the USFDA earlier in December, remains a challenge for Sun. The earnings ...
Sun Pharma said that the US FDA conducted an inspection at the company's Dadra facility from December 4, 2023 to December 15, 2023. The US FDA has subsequently determined the inspection ...
Sun Pharmaceutical Industries witnessed a 3.4% decline in its shares as the US FDA categorized its Dadra ... % decrease from the previous close. Sun Pharma disclosed this classification status ...
The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering the U.S. On March 28, the FDA issued an ...
The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering the U.S. On March 28, the FDA issued an ...
Sun Pharma Slumps 3% Sun Pharma said that the US FDA conducted an inspection at the company's Dadra facility from December 4, 2023 to December 15, 2023. The US FDA has subsequently determined the ...